Acvr1tm1Mak/Acvr1+ Gt(ROSA)26Sortm9(CAG-tdTomato)Hze/Gt(ROSA)26Sor+ Olig2tm1.1(cre)Wdr/Olig2+
involves: 129 * C57BL/6
|
increased oligodendrocyte number |
J:285841
|
Acvr1tm1Mak/Acvr1+ Olig2tm1.1(cre)Wdr/Olig2+
involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6
|
abnormal brain development |
J:285841
|
abnormal brainstem morphology |
J:285841
|
abnormal glial cell physiology |
J:285841
|
ataxia |
J:285841
|
muscle spasm |
J:285841
|
normal
neoplasm |
J:285841
|
preweaning lethality, incomplete penetrance |
J:285841
|
Acvr1tm1Mak/Acvr1+ Gt(ROSA)26Sortm1(Pik3ca*H1047R)Egan/Gt(ROSA)26Sor+ Olig2tm1.1(cre)Wdr/Olig2+
involves: 129 * C57BL/6 * FVB/N
|
increased brain tumor incidence |
J:285841
|
increased glioma incidence |
J:285841
|
Acvr1tm1Mak/Acvr1+ Gt(ROSA)26Sortm1(Pik3ca*H1047R)Egan/Gt(ROSA)26Sor+ H3c2tm1Mak/H3c2+ Olig2tm1.1(cre)Wdr/Olig2+
involves: 129 * C57BL/6 * FVB/N
|
increased brain tumor incidence |
J:285841
|
increased glioma incidence |
J:285841
|
Acvr1tm1Mak/Acvr1+ H3c2tm1Mak/H3c2+ Olig2tm1.1(cre)Wdr/Olig2+
involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6
|
normal
neoplasm |
J:285841
|
postnatal lethality, incomplete penetrance |
J:285841
|
Cdh2tm1Glr/Cdh2tm1Glr Olig2tm1(cre)Tmj/Olig2+
involves: 129S6/SvEvTac
|
abnormal neuronal migration |
J:178688
|
abnormal spinal cord morphology |
J:178688
|
abnormal spinal cord motor column morphology |
J:178688
|
lethality throughout fetal growth and development, incomplete penetrance |
J:178688
|
neonatal lethality, complete penetrance |
J:178688
|
Cspg4tm1Ychan/Cspg4tm1Ychan Olig2tm2(TVA,cre)Rth/Olig2+
involves: 129 * C57BL/6N
|
decreased body weight |
J:184220
|
decreased epididymal fat pad weight |
J:184220
|
Ctnnb1tm2Kem/Ctnnb1tm2Kem Juptm1Ruiz/Juptm1.1Tmj Olig2tm1(cre)Tmj/Olig2+
involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ
|
abnormal dendrite morphology |
J:178688
|
lethality throughout fetal growth and development, complete penetrance |
J:178688
|
Ctnnb1tm2Kem/Ctnnb1tm2Kem Juptm1Ruiz/Juptm1Ruiz Olig2tm1(cre)Tmj/Olig2+
involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ
|
abnormal neuronal migration |
J:178688
|
abnormal spinal cord lateral motor column morphology |
J:178688
|
abnormal spinal cord medial motor column morphology |
J:178688
|
abnormal spinal cord motor column morphology |
J:178688
|
abnormal ventral interneuron 1 morphology |
J:178688
|
abnormal ventral interneuron 2 morphology |
J:178688
|
decreased motor neuron number |
J:178688
|
embryonic lethality during organogenesis, complete penetrance |
J:178688
|
normal
nervous system phenotype |
J:178688
|
Ctnnb1tm2Kem/Ctnnb1tm2Kem Olig2tm1(cre)Tmj/Olig2+
involves: 129S1/Sv * 129X1/SvJ
|
abnormal spinal cord medial motor column morphology |
J:178688
|
decreased motor neuron number |
J:178688
|
neonatal lethality, complete penetrance |
J:178688
|
Gt(ROSA)26Sorem2(Mios)Bcgen/Gt(ROSA)26Sor+ Miostm1Pfw/Miostm1Pfw Olig2tm2(TVA,cre)Rth/Olig2+
involves: 129 * C57BL/6
|
normal
nervous system phenotype |
J:320720
|
Gt(ROSA)26Sortm1(Hoxa2)Fmr/Gt(ROSA)26Sor+ Olig2tm2(TVA,cre)Rth/Olig2+
involves: 129P2/OlaHsd
|
abnormal brain development |
J:193058
|
decreased oligodendrocyte progenitor number |
J:193058
|
Gt(ROSA)26Sortm1(Pik3ca*H1047R)Egan/Gt(ROSA)26Sor+ Olig2tm1.1(cre)Wdr/Olig2+
involves: 129 * C57BL/6 * FVB/N
|
normal
neoplasm |
J:285841
|
Gt(ROSA)26Sortm1(Pik3ca*H1047R)Egan/Gt(ROSA)26Sor+ H3c2tm1Mak/H3c2+ Olig2tm1.1(cre)Wdr/Olig2+
involves: 129 * C57BL/6 * FVB/N
|
normal
neoplasm |
J:285841
|
Gt(ROSA)26Sortm1(Smo/EYFP)Amc/Gt(ROSA)26Sortm1(Smo/EYFP)Amc Olig2tm2(TVA,cre)Rth/Olig2+
involves: 129 * 129X1/SvJ
|
increased medulloblastoma incidence |
J:139574
|
premature death |
J:139574
|
Mapttm1(Sema3e)Yuyo/Mapt+ Olig2tm1(cre)Tmj/Olig2+
Not Specified
|
abnormal excitatory postsynaptic potential |
J:205528
|
abnormal sensory neuron innervation pattern |
J:205528
|
abnormal synaptic bouton morphology |
J:205528
|
normal
nervous system phenotype |
J:205528
|
Miostm1Pfw/Miostm1Pfw Olig2tm2(TVA,cre)Rth/Olig2+
involves: 129 * C57BL/6
|
abnormal oligodendrocyte physiology |
J:320720
|
normal
behavior/neurological phenotype |
J:320720
|
decreased oligodendrocyte number |
J:320720
|
dysmyelination |
J:320720
|
Myrftm1Barr/Myrftm1Barr Olig2tm2(TVA,cre)Rth/Olig2+
involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6
|
abnormal myelination |
J:150563
|
abnormal optic nerve morphology |
J:150563
|
abnormal spinal cord morphology |
J:150563
|
ataxia |
J:150563
|
normal
nervous system phenotype |
J:150563
|
postnatal lethality, complete penetrance |
J:150563
|
seizures |
J:150563
|
tremors |
J:150563
|
Ntf3tm2.1Jae/Ntf3tm2Jae Olig2tm2(cre)Htak/Olig2+
Not Specified
|
abnormal dorsal root ganglion morphology |
J:182750
|
abnormal proprioceptive neuron morphology |
J:182750
|
abnormal sensory neuron innervation pattern |
J:182750
|
Olig1tm1And/Olig1tm1And Olig2tm1And/Olig2tm1And
involves: 129 * C57BL/6J
|
abnormal nervous system development |
J:76446
|
abnormal ventral interneuron 2 morphology |
J:76446
|
absent oligodendrocytes |
J:76446
|
decreased fetal size |
J:76446
|
decreased motor neuron number |
J:76446
|
decreased oligodendrocyte progenitor number |
J:76446
|
perinatal lethality, complete penetrance |
J:76446
|
Olig1tm1And/Olig1tm1And Olig2tm1And/Olig2tm1And Tg(Olig2)#Wdr/?
Not Specified
|
abnormal oligodendrocyte morphology |
J:210099
|
Olig2tm1(cre)Tmj/Olig2+ Shhtm2Amc/Shhtm2Amc
involves: 129S1/Sv * 129X1/SvJ
|
abnormal spinal cord lateral motor column morphology |
J:277700
|
decreased motor neuron number |
J:277700
|
normal
nervous system phenotype |
J:277700
|
Olig2tm1(cre)Tmj/Olig2+ Smn1tm1Jme/Smn1tm1Msd Grm7Tg(SMN2)89Ahmb/Grm7+
involves: 129 * 129P2/OlaHsd * FVB/N
|
postnatal lethality, complete penetrance |
J:164292
|
Olig2tm1(cre)Tmj/Olig2+ Smn1tm1Jme/Smn1tm1Msd Grm7Tg(SMN2)89Ahmb/Grm7Tg(SMN2)89Ahmb
involves: 129 * 129P2/OlaHsd * FVB/N
|
abnormal CNS synaptic transmission |
J:164292
|
abnormal miniature endplate potential |
J:164292
|
abnormal muscle morphology |
J:164292
|
abnormal neuromuscular synapse morphology |
J:164292
|
abnormal PNS synaptic transmission |
J:164292
|
abnormal sensory neuron innervation pattern |
J:164292
|
abnormal synaptic bouton morphology |
J:164292
|
abnormal synaptic transmission |
J:164292
|
decreased body weight |
J:164292
|
decreased grip strength |
J:164292
|
decreased skeletal muscle fiber number |
J:164292
|
decreased survivor rate |
J:164292
|
increased skeletal muscle fiber size |
J:164292
|
kyphosis |
J:164292
|
motor neuron degeneration |
J:164292
|
muscle weakness |
J:164292
|
muscular atrophy |
J:164292
|
premature death |
J:164292
|
skeletal muscle fiber degeneration |
J:164292
|
Prrc2atm1Fcw/Prrc2atm1Fcw Olig2tm2(TVA,cre)Rth/Olig2+
involves: 129 * C57BL/6
|
abnormal brain morphology |
J:301796
|
abnormal corpus callosum morphology |
J:301796
|
decreased body weight |
J:301796
|
decreased grip strength |
J:301796
|
decreased oligodendrocyte number |
J:301796
|
decreased oligodendrocyte progenitor number |
J:301796
|
dysmyelination |
J:301796
|
enlarged lateral ventricles |
J:301796
|
impaired coordination |
J:301796
|
impaired spatial learning |
J:301796
|
increased brain weight |
J:301796
|
normal
nervous system phenotype |
J:301796
|
premature death |
J:301796
|